Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 434 entries
Sorted by: Best Match Show Resources per page
The Joseph M. Still Burn Symposium.

Annals of plastic surgery

Lineaweaver WC, Hills J, Mullins F.
PMID: 29319566
Ann Plast Surg. 2018 Mar;80(3):S87. doi: 10.1097/SAP.0000000000001269.

No abstract available.

Cite
Lineaweaver WC, Hills J, Mullins F. The Joseph M. Still Burn Symposium. Ann Plast Surg. 2018;80(3):S87doi: 10.1097/SAP.0000000000001269.
Lineaweaver, W. C., Hills, J., & Mullins, F. (2018). The Joseph M. Still Burn Symposium. Annals of plastic surgery, 80(3), S87. https://doi.org/10.1097/SAP.0000000000001269
Lineaweaver, William C, et al. "The Joseph M. Still Burn Symposium." Annals of plastic surgery vol. 80,3 (2018): S87. doi: https://doi.org/10.1097/SAP.0000000000001269
Lineaweaver WC, Hills J, Mullins F. The Joseph M. Still Burn Symposium. Ann Plast Surg. 2018 Mar;80(3):S87. doi: 10.1097/SAP.0000000000001269. PMID: 29319566.
Copy Download .nbib Format: NLM
Insuring nanotech requires effective risk communication.

Nature nanotechnology

Murphy F, Mullins M, Hester K, Gelwick A, Scott-Fordsmand JJ, Maynard T.
PMID: 28775357
Nat Nanotechnol. 2017 Aug 04;12(8):717-719. doi: 10.1038/nnano.2017.162.

No abstract available.

Cite
Murphy F, Mullins M, Hester K, et al. Insuring nanotech requires effective risk communication. Nat Nanotechnol. 2017;12(8):717-719doi: 10.1038/nnano.2017.162.
Murphy, F., Mullins, M., Hester, K., Gelwick, A., Scott-Fordsmand, J. J., & Maynard, T. (2017). Insuring nanotech requires effective risk communication. Nature nanotechnology, 12(8), 717-719. https://doi.org/10.1038/nnano.2017.162
Murphy, Finbarr, et al. "Insuring nanotech requires effective risk communication." Nature nanotechnology vol. 12,8 (2017): 717-719. doi: https://doi.org/10.1038/nnano.2017.162
Murphy F, Mullins M, Hester K, Gelwick A, Scott-Fordsmand JJ, Maynard T. Insuring nanotech requires effective risk communication. Nat Nanotechnol. 2017 Aug 04;12(8):717-719. doi: 10.1038/nnano.2017.162. PMID: 28775357.
Copy Download .nbib Format: NLM
What happens before, during and after crisis for someone with dementia living at home: A systematic review.

Dementia (London, England)

Hopkinson JB, King A, Mullins J, Young L, Kumar S, Hydon K, Muthukrishnan S, Elliott F, Hopkinson M.
PMID: 32013558
Dementia (London). 2021 Feb;20(2):570-612. doi: 10.1177/1471301220901634. Epub 2020 Feb 03.

BACKGROUND: People living with dementia often experience crisis. Home treatment of crisis is an alternative to hospital admission that can have better outcomes. This systematic review is about people with dementia living at home and in crisis. It identifies...

Cite
Hopkinson JB, King A, Mullins J, et al. What happens before, during and after crisis for someone with dementia living at home: A systematic review. Dementia (London). 2020;20(2):570-612doi: 10.1177/1471301220901634.
Hopkinson, J. B., King, A., Mullins, J., Young, L., Kumar, S., Hydon, K., Muthukrishnan, S., Elliott, F., & Hopkinson, M. (2021). What happens before, during and after crisis for someone with dementia living at home: A systematic review. Dementia (London, England), 20(2), 570-612. https://doi.org/10.1177/1471301220901634
Hopkinson, Jane B, et al. "What happens before, during and after crisis for someone with dementia living at home: A systematic review." Dementia (London, England) vol. 20,2 (2021): 570-612. doi: https://doi.org/10.1177/1471301220901634
Hopkinson JB, King A, Mullins J, Young L, Kumar S, Hydon K, Muthukrishnan S, Elliott F, Hopkinson M. What happens before, during and after crisis for someone with dementia living at home: A systematic review. Dementia (London). 2021 Feb;20(2):570-612. doi: 10.1177/1471301220901634. Epub 2020 Feb 03. PMID: 32013558.
Copy Download .nbib Format: NLM
Assessment of genetically modified maize Bt11 × MIR162 × MIR604 × 1507 × 5307 × GA21 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-DE-2011-103).

EFSA journal. European Food Safety Authority

, Naegeli H, Bresson JL, Dalmay T, Dewhurst IC, Epstein MM, Firbank LG, Guerche P, Hejatko J, Moreno FJ, Mullins E, Nogué F, Rostoks N, Sánchez Serrano JJ, Savoini G, Veromann E, Veronesi F, Ardizzone M, Álvarez F, Fernandez Dumont A, Gennaro A, Lanzoni A, Neri FM, Papadopoulou N, Paraskevopoulos K, De Sanctis G, Raffaello T, Federici S, Koukoulanaki M.
PMID: 32626276
EFSA J. 2019 Apr 05;17(4):e05635. doi: 10.2903/j.efsa.2019.5635. eCollection 2019 Apr.

Maize Bt11 × MIR162 × MIR604 × 1507 × 5307 × GA21 (six-event stack maize) was produced by conventional crossing to combine six single events: Bt11, MIR162, MIR604, 1507, 5307 and GA21. The GMO Panel previously assessed the six...

Cite
, Naegeli H, Bresson JL, et al. Assessment of genetically modified maize Bt11 × MIR162 × MIR604 × 1507 × 5307 × GA21 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-DE-2011-103). EFSA J. 2019;17(4):e05635doi: 10.2903/j.efsa.2019.5635.
, Naegeli, H., Bresson, J. L., Dalmay, T., Dewhurst, I. C., Epstein, M. M., Firbank, L. G., Guerche, P., Hejatko, J., Moreno, F. J., Mullins, E., Nogué, F., Rostoks, N., Sánchez Serrano, J. J., Savoini, G., Veromann, E., Veronesi, F., Ardizzone, M., Álvarez, F., Fernandez Dumont, A., Gennaro, A., Lanzoni, A., Neri, F. M., Papadopoulou, N., Paraskevopoulos, K., De Sanctis, G., Raffaello, T., Federici, S., & Koukoulanaki, M. (2019). Assessment of genetically modified maize Bt11 × MIR162 × MIR604 × 1507 × 5307 × GA21 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-DE-2011-103). EFSA journal. European Food Safety Authority, 17(4), e05635. https://doi.org/10.2903/j.efsa.2019.5635
, et al. "Assessment of genetically modified maize Bt11 × MIR162 × MIR604 × 1507 × 5307 × GA21 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-DE-2011-103)." EFSA journal. European Food Safety Authority vol. 17,4 (2019): e05635. doi: https://doi.org/10.2903/j.efsa.2019.5635
, Naegeli H, Bresson JL, Dalmay T, Dewhurst IC, Epstein MM, Firbank LG, Guerche P, Hejatko J, Moreno FJ, Mullins E, Nogué F, Rostoks N, Sánchez Serrano JJ, Savoini G, Veromann E, Veronesi F, Ardizzone M, Álvarez F, Fernandez Dumont A, Gennaro A, Lanzoni A, Neri FM, Papadopoulou N, Paraskevopoulos K, De Sanctis G, Raffaello T, Federici S, Koukoulanaki M. Assessment of genetically modified maize Bt11 × MIR162 × MIR604 × 1507 × 5307 × GA21 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-DE-2011-103). EFSA J. 2019 Apr 05;17(4):e05635. doi: 10.2903/j.efsa.2019.5635. eCollection 2019 Apr. PMID: 32626276; PMCID: PMC7009178.
Copy Download .nbib Format: NLM
Statement complementing the EFSA Scientific Opinion on application (EFSA-GMO-UK-2006-34) for authorisation of food and feed containing, consisting of and produced from genetically modified maize 3272.

EFSA journal. European Food Safety Authority

, Naegeli H, Bresson JL, Dalmay T, Dewhurst IC, Epstein MM, Firbank LG, Guerche P, Hejatko J, Moreno FJ, Mullins E, Nogué F, Rostoks N, Sánchez Serrano JJ, Savoini G, Veromann E, Veronesi F, Álvarez F, Ardizzone M, Lanzoni A, Gómez Ruiz JÁ, De Sanctis G, Fernández Dumont A, Gennaro A, Neri FM.
PMID: 32626151
EFSA J. 2019 Nov 04;17(11):e05844. doi: 10.2903/j.efsa.2019.5844. eCollection 2019 Nov.

Following a request from the European Commission, the GMO Panel assessed additional information related to the application for authorisation of food and feed containing, consisting of and produced from genetically modified (GM) maize 3272 (EFSA-GMO-UK-2006-34). The applicant conducted new...

Cite
, Naegeli H, Bresson JL, et al. Statement complementing the EFSA Scientific Opinion on application (EFSA-GMO-UK-2006-34) for authorisation of food and feed containing, consisting of and produced from genetically modified maize 3272. EFSA J. 2019;17(11):e05844doi: 10.2903/j.efsa.2019.5844.
, Naegeli, H., Bresson, J. L., Dalmay, T., Dewhurst, I. C., Epstein, M. M., Firbank, L. G., Guerche, P., Hejatko, J., Moreno, F. J., Mullins, E., Nogué, F., Rostoks, N., Sánchez Serrano, J. J., Savoini, G., Veromann, E., Veronesi, F., Álvarez, F., Ardizzone, M., Lanzoni, A., Gómez Ruiz, J. �. �., De Sanctis, G., Fernández Dumont, A., Gennaro, A., & Neri, F. M. (2019). Statement complementing the EFSA Scientific Opinion on application (EFSA-GMO-UK-2006-34) for authorisation of food and feed containing, consisting of and produced from genetically modified maize 3272. EFSA journal. European Food Safety Authority, 17(11), e05844. https://doi.org/10.2903/j.efsa.2019.5844
, et al. "Statement complementing the EFSA Scientific Opinion on application (EFSA-GMO-UK-2006-34) for authorisation of food and feed containing, consisting of and produced from genetically modified maize 3272." EFSA journal. European Food Safety Authority vol. 17,11 (2019): e05844. doi: https://doi.org/10.2903/j.efsa.2019.5844
, Naegeli H, Bresson JL, Dalmay T, Dewhurst IC, Epstein MM, Firbank LG, Guerche P, Hejatko J, Moreno FJ, Mullins E, Nogué F, Rostoks N, Sánchez Serrano JJ, Savoini G, Veromann E, Veronesi F, Álvarez F, Ardizzone M, Lanzoni A, Gómez Ruiz JÁ, De Sanctis G, Fernández Dumont A, Gennaro A, Neri FM. Statement complementing the EFSA Scientific Opinion on application (EFSA-GMO-UK-2006-34) for authorisation of food and feed containing, consisting of and produced from genetically modified maize 3272. EFSA J. 2019 Nov 04;17(11):e05844. doi: 10.2903/j.efsa.2019.5844. eCollection 2019 Nov. PMID: 32626151; PMCID: PMC7008843.
Copy Download .nbib Format: NLM
Assessment of genetically modified maize MON 89034 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-015).

EFSA journal. European Food Safety Authority

, Naegeli H, Bresson JL, Dalmay T, Dewhurst IC, Epstein MM, Firbank LG, Guerche P, Hejatko J, Moreno FJ, Mullins E, Nogué F, Rostoks N, Sánchez Serrano JJ, Savoini G, Veromann E, Veronesi F, Álvarez F, Ardizzone M, Raffaello T.
PMID: 32626152
EFSA J. 2019 Nov 07;17(11):e05845. doi: 10.2903/j.efsa.2019.5845. eCollection 2019 Nov.

Following the submission of application EFSA-GMO-RX-015 under Regulation (EC) No 1829/2003 from Bayer Agriculture BVBA, the EFSA Panel on Genetically Modified Organisms (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the context...

Cite
, Naegeli H, Bresson JL, et al. Assessment of genetically modified maize MON 89034 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-015). EFSA J. 2019;17(11):e05845doi: 10.2903/j.efsa.2019.5845.
, Naegeli, H., Bresson, J. L., Dalmay, T., Dewhurst, I. C., Epstein, M. M., Firbank, L. G., Guerche, P., Hejatko, J., Moreno, F. J., Mullins, E., Nogué, F., Rostoks, N., Sánchez Serrano, J. J., Savoini, G., Veromann, E., Veronesi, F., Álvarez, F., Ardizzone, M., & Raffaello, T. (2019). Assessment of genetically modified maize MON 89034 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-015). EFSA journal. European Food Safety Authority, 17(11), e05845. https://doi.org/10.2903/j.efsa.2019.5845
, et al. "Assessment of genetically modified maize MON 89034 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-015)." EFSA journal. European Food Safety Authority vol. 17,11 (2019): e05845. doi: https://doi.org/10.2903/j.efsa.2019.5845
, Naegeli H, Bresson JL, Dalmay T, Dewhurst IC, Epstein MM, Firbank LG, Guerche P, Hejatko J, Moreno FJ, Mullins E, Nogué F, Rostoks N, Sánchez Serrano JJ, Savoini G, Veromann E, Veronesi F, Álvarez F, Ardizzone M, Raffaello T. Assessment of genetically modified maize MON 89034 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-015). EFSA J. 2019 Nov 07;17(11):e05845. doi: 10.2903/j.efsa.2019.5845. eCollection 2019 Nov. PMID: 32626152; PMCID: PMC7008809.
Copy Download .nbib Format: NLM
Assessment of genetically modified maize MON 87427 × MON 89034 × MIR162 × MON 87411 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2017-144).

EFSA journal. European Food Safety Authority

, Naegeli H, Bresson JL, Dalmay T, Dewhurst IC, Epstein MM, Firbank LG, Guerche P, Hejatko J, Moreno FJ, Mullins E, Nogué F, Rostoks N, Sánchez Serrano JJ, Savoini G, Veromann E, Veronesi F, Álvarez F, Ardizzone M, De Sanctis G, Fernandez Dumont A, Gennaro A, Gómez Ruiz JÁ, Lanzoni A, Neri FM, Papadopoulou N, Paraskevopoulos K.
PMID: 32626155
EFSA J. 2019 Nov 07;17(11):e05848. doi: 10.2903/j.efsa.2019.5848. eCollection 2019 Nov.

Maize MON 87427 × MON 89034 × MIR162 × MON 87411 (four-event stack maize) was produced by conventional crossing to combine four single events: MON 87427, MON 89034, MIR162 and MON 87411. The genetically modified organism (GMO) Panel previously...

Cite
, Naegeli H, Bresson JL, et al. Assessment of genetically modified maize MON 87427 × MON 89034 × MIR162 × MON 87411 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2017-144). EFSA J. 2019;17(11):e05848doi: 10.2903/j.efsa.2019.5848.
, Naegeli, H., Bresson, J. L., Dalmay, T., Dewhurst, I. C., Epstein, M. M., Firbank, L. G., Guerche, P., Hejatko, J., Moreno, F. J., Mullins, E., Nogué, F., Rostoks, N., Sánchez Serrano, J. J., Savoini, G., Veromann, E., Veronesi, F., Álvarez, F., Ardizzone, M., De Sanctis, G., Fernandez Dumont, A., Gennaro, A., Gómez Ruiz, J. �. �., Lanzoni, A., Neri, F. M., Papadopoulou, N., & Paraskevopoulos, K. (2019). Assessment of genetically modified maize MON 87427 × MON 89034 × MIR162 × MON 87411 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2017-144). EFSA journal. European Food Safety Authority, 17(11), e05848. https://doi.org/10.2903/j.efsa.2019.5848
, et al. "Assessment of genetically modified maize MON 87427 × MON 89034 × MIR162 × MON 87411 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2017-144)." EFSA journal. European Food Safety Authority vol. 17,11 (2019): e05848. doi: https://doi.org/10.2903/j.efsa.2019.5848
, Naegeli H, Bresson JL, Dalmay T, Dewhurst IC, Epstein MM, Firbank LG, Guerche P, Hejatko J, Moreno FJ, Mullins E, Nogué F, Rostoks N, Sánchez Serrano JJ, Savoini G, Veromann E, Veronesi F, Álvarez F, Ardizzone M, De Sanctis G, Fernandez Dumont A, Gennaro A, Gómez Ruiz JÁ, Lanzoni A, Neri FM, Papadopoulou N, Paraskevopoulos K. Assessment of genetically modified maize MON 87427 × MON 89034 × MIR162 × MON 87411 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2017-144). EFSA J. 2019 Nov 07;17(11):e05848. doi: 10.2903/j.efsa.2019.5848. eCollection 2019 Nov. PMID: 32626155; PMCID: PMC7008898.
Copy Download .nbib Format: NLM
Ejection of Droplets from a Bursting Bubble on a Free Liquid Surface-A Dimensionless Criterion for "Jet" Droplets.

Langmuir : the ACS journal of surfaces and colloids

Mead-Hunter R, Gumulya MM, King AJC, Mullins BJ.
PMID: 29737855
Langmuir. 2018 May 29;34(21):6307-6313. doi: 10.1021/acs.langmuir.8b00664. Epub 2018 May 18.

This work examines the ejection of droplets from a bursting gas bubble on a free liquid surface, both experimentally and numerically. We explore the physical processes which govern the bursting of bubbles and the subsequent formation of "jet" droplets....

Cite
Mead-Hunter R, Gumulya MM, King AJC, et al. Ejection of Droplets from a Bursting Bubble on a Free Liquid Surface-A Dimensionless Criterion for "Jet" Droplets. Langmuir. 2018;34(21):6307-6313doi: 10.1021/acs.langmuir.8b00664.
Mead-Hunter, R., Gumulya, M. M., King, A. J. C., & Mullins, B. J. (2018). Ejection of Droplets from a Bursting Bubble on a Free Liquid Surface-A Dimensionless Criterion for "Jet" Droplets. Langmuir : the ACS journal of surfaces and colloids, 34(21), 6307-6313. https://doi.org/10.1021/acs.langmuir.8b00664
Mead-Hunter, Ryan, et al. "Ejection of Droplets from a Bursting Bubble on a Free Liquid Surface-A Dimensionless Criterion for "Jet" Droplets." Langmuir : the ACS journal of surfaces and colloids vol. 34,21 (2018): 6307-6313. doi: https://doi.org/10.1021/acs.langmuir.8b00664
Mead-Hunter R, Gumulya MM, King AJC, Mullins BJ. Ejection of Droplets from a Bursting Bubble on a Free Liquid Surface-A Dimensionless Criterion for "Jet" Droplets. Langmuir. 2018 May 29;34(21):6307-6313. doi: 10.1021/acs.langmuir.8b00664. Epub 2018 May 18. PMID: 29737855.
Copy Download .nbib Format: NLM
Solubility of Iridium and Ruthenium Organometallic Photoredox Catalysts.

Organic process research & development

Jespersen D, Keen B, Day JI, Singh A, Briles J, Mullins D, Weaver JD.
PMID: 31396008
Org Process Res Dev. 2019 May 17;23(5):1087-1095. doi: 10.1021/acs.oprd.9b00041. Epub 2019 Mar 18.

Despite the exponential growth of the field of photocatalysis, for reasons that are not entirely clear, these precious photocatalysts are often used in the literature at loadings that exceed their maximum solubility. On an industrial scale, the quantity of...

Cite
Jespersen D, Keen B, Day JI, et al. Solubility of Iridium and Ruthenium Organometallic Photoredox Catalysts. Org Process Res Dev. 2019;23(5):1087-1095doi: 10.1021/acs.oprd.9b00041.
Jespersen, D., Keen, B., Day, J. I., Singh, A., Briles, J., Mullins, D., & Weaver, J. D. (2019). Solubility of Iridium and Ruthenium Organometallic Photoredox Catalysts. Organic process research & development, 23(5), 1087-1095. https://doi.org/10.1021/acs.oprd.9b00041
Jespersen, Daniel, et al. "Solubility of Iridium and Ruthenium Organometallic Photoredox Catalysts." Organic process research & development vol. 23,5 (2019): 1087-1095. doi: https://doi.org/10.1021/acs.oprd.9b00041
Jespersen D, Keen B, Day JI, Singh A, Briles J, Mullins D, Weaver JD. Solubility of Iridium and Ruthenium Organometallic Photoredox Catalysts. Org Process Res Dev. 2019 May 17;23(5):1087-1095. doi: 10.1021/acs.oprd.9b00041. Epub 2019 Mar 18. PMID: 31396008; PMCID: PMC6687329.
Copy Download .nbib Format: NLM
Morbid jealousy: The green-eyed monster.

Irish journal of psychological medicine

Mullins D.
PMID: 30282234
Ir J Psychol Med. 2010 Jun;27(2):i-vii. doi: 10.1017/S0790966700001221.

Jealousy is a commonly experienced emotion which has been observed in infants as young as 5-6 months of age and across the lifespan of an individual. In its extreme form jealousy can be pathological, when the belief which may...

Cite
Mullins D. Morbid jealousy: The green-eyed monster. Ir J Psychol Med. 2010;27(2):i-viidoi: 10.1017/S0790966700001221.
Mullins, D. (2010). Morbid jealousy: The green-eyed monster. Irish journal of psychological medicine, 27(2), i-vii. https://doi.org/10.1017/S0790966700001221
Mullins, Diane. "Morbid jealousy: The green-eyed monster." Irish journal of psychological medicine vol. 27,2 (2010): i-vii. doi: https://doi.org/10.1017/S0790966700001221
Mullins D. Morbid jealousy: The green-eyed monster. Ir J Psychol Med. 2010 Jun;27(2):i-vii. doi: 10.1017/S0790966700001221. PMID: 30282234.
Copy Download .nbib Format: NLM
Diabetes mellitus and prostate cancer risk.

Expert review of endocrinology & metabolism

Mullins JK, Loeb S.
PMID: 30780835
Expert Rev Endocrinol Metab. 2010 Nov;5(6):787-789. doi: 10.1586/eem.10.64.

No abstract available.

Cite
Mullins JK, Loeb S. Diabetes mellitus and prostate cancer risk. Expert Rev Endocrinol Metab. 2010;5(6):787-789doi: 10.1586/eem.10.64.
Mullins, J. K., & Loeb, S. (2010). Diabetes mellitus and prostate cancer risk. Expert review of endocrinology & metabolism, 5(6), 787-789. https://doi.org/10.1586/eem.10.64
Mullins, Jeffrey K, and Loeb, Stacy. "Diabetes mellitus and prostate cancer risk." Expert review of endocrinology & metabolism vol. 5,6 (2010): 787-789. doi: https://doi.org/10.1586/eem.10.64
Mullins JK, Loeb S. Diabetes mellitus and prostate cancer risk. Expert Rev Endocrinol Metab. 2010 Nov;5(6):787-789. doi: 10.1586/eem.10.64. PMID: 30780835.
Copy Download .nbib Format: NLM
Oxygen prescription: improving compliance using methods from .

BMJ open quality

Thein OS, Chan CMT, McCance E, Mullins M, Dosanjh D.
PMID: 29946572
BMJ Open Qual. 2018 Jun 04;7(2):e000288. doi: 10.1136/bmjoq-2017-000288. eCollection 2018.

Oxygen is an important drug frequently used in the management of acutely unwell hospital patients. However, oxygen overuse can have fatal side effects particularly for those patients at risk of iatrogenic hypercapnia. British Thoracic Society Guidelines state that oxygen...

Cite
Thein OS, Chan CMT, McCance E, et al. Oxygen prescription: improving compliance using methods from . BMJ Open Qual. 2018;7(2):e000288doi: 10.1136/bmjoq-2017-000288.
Thein, O. S., Chan, C. M. T., McCance, E., Mullins, M., & Dosanjh, D. (2018). Oxygen prescription: improving compliance using methods from . BMJ open quality, 7(2), e000288. https://doi.org/10.1136/bmjoq-2017-000288
Thein, Onn Shaun, et al. "Oxygen prescription: improving compliance using methods from ." BMJ open quality vol. 7,2 (2018): e000288. doi: https://doi.org/10.1136/bmjoq-2017-000288
Thein OS, Chan CMT, McCance E, Mullins M, Dosanjh D. Oxygen prescription: improving compliance using methods from . BMJ Open Qual. 2018 Jun 04;7(2):e000288. doi: 10.1136/bmjoq-2017-000288. eCollection 2018. PMID: 29946572; PMCID: PMC6014230.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 434 entries